Ya have to figure when all is said and done the OS could reach as much as 100M So depending on if we can become SOC and do some successful combination clinicals I'm leaning more with BLU's valuation around $10 within next 3 years give or take. Now if they can get to $10 on their own there is no saying what a BO price would be. The market space is in the Billions and we may also be able to treat other types of cancers in time along with infectious diseases. Would br happy with a 1/3 of $100. I'm already too pretentious now ;-)
Market Data 
Markets 
AI
